Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, placebo-controlled, parallel-group comparative study.
about
Efficacy and Safety of Teneligliptin 40 mg in Type 2 Diabetes: A Pooled Analysis of Two Phase III Clinical Studies.Safety and Efficacy of Teneligliptin in Patients with Type 2 Diabetes Mellitus and Impaired Renal Function: Interim Report from Post-marketing Surveillance.Efficacy and Safety of Teneligliptin in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
P2860
Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, placebo-controlled, parallel-group comparative study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Efficacy and safety of tenelig ...... allel-group comparative study.
@en
Efficacy and safety of tenelig ...... allel-group comparative study.
@nl
type
label
Efficacy and safety of tenelig ...... allel-group comparative study.
@en
Efficacy and safety of tenelig ...... allel-group comparative study.
@nl
prefLabel
Efficacy and safety of tenelig ...... allel-group comparative study.
@en
Efficacy and safety of tenelig ...... allel-group comparative study.
@nl
P2093
P2860
P356
P1476
Efficacy and safety of tenelig ...... rallel-group comparative study
@en
P2093
Genki Kaneko
Hiroaki Iijima
Kazuoki Kondo
Kenichi Nishimura
Maki Gouda
Nobuhiro Nakanishi
Nobuko Maruyama
Nobuya Inagaki
Takashi Kadowaki
P2860
P304
P356
10.1111/DOM.13079
P577
2017-09-15T00:00:00Z